Amedisys (AMED) News Today → get a piece of the profit from this land (From True Market Insiders) (Ad) Free AMED Stock Alerts $94.43 -0.52 (-0.55%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 9:08 AM | marketbeat.comFirst Eagle Investment Management LLC Sells 46,876 Shares of Amedisys, Inc. (NASDAQ:AMED)First Eagle Investment Management LLC cut its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 64.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,300 shares of the health services provMay 17 at 4:54 AM | marketbeat.comSwiss National Bank Sells 10,600 Shares of Amedisys, Inc. (NASDAQ:AMED)Swiss National Bank decreased its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 14.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 61,100 shares of the health services provider's stock afterMay 16 at 8:59 AM | marketbeat.comBoston Partners Sells 8,004 Shares of Amedisys, Inc. (NASDAQ:AMED)Boston Partners lessened its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 203,697 shares of the health services provider's stock after selling 8,004 shares duringMay 11, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Sold by Versor Investments LPVersor Investments LP lessened its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 40.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 24,286 shares of the health serviceMay 9, 2024 | marketbeat.com344,795 Shares in Amedisys, Inc. (NASDAQ:AMED) Purchased by Segantii Capital Management LtdSegantii Capital Management Ltd acquired a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 344,795 shares of the health services provider's stocMay 8, 2024 | msn.comAmedisys gains amid report of sweetened divestiture offer in UnitedHealth dealMay 7, 2024 | fool.comAmedisys (NASDAQ: AMED)May 3, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Bought by New York Life Investment Management LLCNew York Life Investment Management LLC increased its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 22.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 93,992 shares of the health services provider's stock after puMay 1, 2024 | finance.yahoo.comAmedisys, Inc. (AMED)May 1, 2024 | marketbeat.comHandelsbanken Fonder AB Reduces Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)Handelsbanken Fonder AB cut its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 94.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,251 shares of the health services provider's stock afApril 30, 2024 | msn.comUnitedHealth grew very big. Now, some lawmakers want to chop it down.April 26, 2024 | marketbeat.comStockNews.com Lowers Amedisys (NASDAQ:AMED) to HoldStockNews.com downgraded Amedisys from a "buy" rating to a "hold" rating in a report on Friday.April 26, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Amedisys, Inc. Issued By William Blair (NASDAQ:AMED)Amedisys, Inc. (NASDAQ:AMED - Free Report) - Equities researchers at William Blair increased their Q2 2024 earnings per share (EPS) estimates for Amedisys in a research report issued on Thursday, April 25th. William Blair analyst M. Larew now expects that the health services provider will post eaApril 26, 2024 | marketbeat.comLouisiana State Employees Retirement System Buys New Shares in Amedisys, Inc. (NASDAQ:AMED)Louisiana State Employees Retirement System acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 9,200 shares of the health services provideApril 25, 2024 | finanznachrichten.deAmedisys, Inc.: Amedisys Reports First Quarter 2024 Financial ResultsApril 25, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Hold Rating on Amedisys (AMED)April 25, 2024 | sfgate.comAmedisys: Q1 Earnings SnapshotApril 25, 2024 | marketbeat.comAmedisys (NASDAQ:AMED) Announces Earnings Results, Beats Estimates By $0.01 EPSAmedisys (NASDAQ:AMED - Get Free Report) released its earnings results on Wednesday. The health services provider reported $1.03 EPS for the quarter, topping analysts' consensus estimates of $1.02 by $0.01. The firm had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The business's quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 EPS.April 25, 2024 | marketbeat.comCantor Fitzgerald Reaffirms "Neutral" Rating for Amedisys (NASDAQ:AMED)Cantor Fitzgerald restated a "neutral" rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday.April 25, 2024 | investorplace.comAMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024April 24, 2024 | globenewswire.comAmedisys Reports First Quarter 2024 Financial ResultsApril 23, 2024 | marketbeat.comStrs Ohio Acquires Shares of 14,271 Amedisys, Inc. (NASDAQ:AMED)Strs Ohio acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 14,271 shares of the health services provider's stock, valued at approxApril 19, 2024 | msn.comDOJ case against UnitedHealth could take years to resolve, says BoAApril 19, 2024 | finance.yahoo.comInterim HealthCare Appoints New Clinical Quality LeaderApril 19, 2024 | marketbeat.comCalamos Advisors LLC Invests $23.02 Million in Amedisys, Inc. (NASDAQ:AMED)Calamos Advisors LLC acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 242,110 shares of the health services provider's stock, valued at approximately $23,April 16, 2024 | marketbeat.comMackenzie Financial Corp Sells 63,311 Shares of Amedisys, Inc. (NASDAQ:AMED)Mackenzie Financial Corp trimmed its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 6.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 877,747 shares of the health services provider's stock afterApril 13, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Short Interest UpdateAmedisys, Inc. (NASDAQ:AMED - Get Free Report) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 2,490,000 shares, a decrease of 20.2% from the March 15th total of 3,120,000 shares. Approximately 7.8% of the shares of the stock are sold short. Based on an average daily trading volume, of 291,300 shares, the short-interest ratio is presently 8.5 days.April 13, 2024 | marketbeat.comMRP Capital Investments LLC Purchases 16,185 Shares of Amedisys, Inc. (NASDAQ:AMED)MRP Capital Investments LLC lifted its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 448.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,795 shares of thApril 11, 2024 | msn.comImpact of aldehydes on DNA damage and agingApril 9, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Receives Average Recommendation of "Hold" from BrokeragesShares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have earned a consensus rating of "Hold" from the eight analysts that are presently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating and one has given a buy rating to the company. The averApril 8, 2024 | marketbeat.comStockNews.com Initiates Coverage on Amedisys (NASDAQ:AMED)StockNews.com began coverage on shares of Amedisys in a report on Monday. They set a "buy" rating for the company.April 7, 2024 | marketbeat.comVaughan Nelson Investment Management L.P. Buys 11,670 Shares of Amedisys, Inc. (NASDAQ:AMED)Vaughan Nelson Investment Management L.P. lifted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 285,803 shares of the health services provider's stoApril 3, 2024 | finance.yahoo.comSurescripts exploring a sale: reportMarch 28, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 0.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,241,160 shares of the health services provider'sMarch 26, 2024 | marketbeat.comAmedisys' (AMED) Market Perform Rating Reaffirmed at Raymond JamesRaymond James reaffirmed a "market perform" rating on shares of Amedisys in a report on Tuesday.March 25, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Amedisys (AMED) and Masimo (MASI)March 25, 2024 | msn.comUnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC SaysMarch 25, 2024 | marketbeat.comAmedisys (NASDAQ:AMED) Given New $100.00 Price Target at Royal Bank of CanadaRoyal Bank of Canada increased their price objective on shares of Amedisys from $97.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday.March 24, 2024 | marketbeat.comSG Americas Securities LLC Buys 41,206 Shares of Amedisys, Inc. (NASDAQ:AMED)SG Americas Securities LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 181.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,953 shares of the health services provider's sMarch 20, 2024 | msn.comAmedisys dips amid report DOJ considering lawsuit to block UnitedHealth dealMarch 20, 2024 | marketbeat.comAmedisys (NASDAQ:AMED) Sees Strong Trading VolumeAmedisys (NASDAQ:AMED) Sees Unusually-High Trading VolumeMarch 19, 2024 | reuters.comOregon's health authority reviewing UnitedHealth's acquisition of AmedisysMarch 18, 2024 | marketbeat.comWellington Management Group LLP Decreases Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)Wellington Management Group LLP trimmed its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 38.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 981,050 shares of the health services provider's stock after sMarch 13, 2024 | marketbeat.comHudson Bay Capital Management LP Has $15.55 Million Stock Position in Amedisys, Inc. (NASDAQ:AMED)Hudson Bay Capital Management LP boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 926.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 166,456 shares of the health services provider's stockMarch 12, 2024 | marketbeat.comQube Research & Technologies Ltd Invests $1.98 Million in Amedisys, Inc. (NASDAQ:AMED)Qube Research & Technologies Ltd purchased a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 21,233 shares of the health services provider's stock, valued at approximately $1March 10, 2024 | marketbeat.comNorthern Trust Corp Reduces Holdings in Amedisys, Inc. (NASDAQ:AMED)Northern Trust Corp reduced its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 23.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 246,234 shares of the health services provider's sMarch 7, 2024 | marketbeat.comQ2 2024 EPS Estimates for Amedisys, Inc. (NASDAQ:AMED) Lifted by Leerink PartnrsAmedisys, Inc. (NASDAQ:AMED - Free Report) - Stock analysts at Leerink Partnrs increased their Q2 2024 earnings per share estimates for Amedisys in a research report issued to clients and investors on Monday, March 4th. Leerink Partnrs analyst W. Mayo now expects that the health services providerMarch 6, 2024 | marketbeat.comQ1 2024 Earnings Estimate for Amedisys, Inc. Issued By Leerink Partnrs (NASDAQ:AMED)Amedisys, Inc. (NASDAQ:AMED - Free Report) - Equities researchers at Leerink Partnrs increased their Q1 2024 EPS estimates for Amedisys in a research report issued to clients and investors on Monday, March 4th. Leerink Partnrs analyst W. Mayo now anticipates that the health services provider willMarch 5, 2024 | marketbeat.comToronto Dominion Bank Makes New Investment in Amedisys, Inc. (NASDAQ:AMED)Toronto Dominion Bank purchased a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 51,500 shares of the health services provider's stock, valued at appMarch 3, 2024 | marketbeat.comAlberta Investment Management Corp Purchases 32,923 Shares of Amedisys, Inc. (NASDAQ:AMED)Alberta Investment Management Corp grew its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 181.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 51,104 shares of the health services provider's stock after acquirin Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address Millionaire Investor makes surprising election prediction (Ad)Millionaire Investor Makes Surprising Election Prediction Louis Navellier says he knows who's going to win the election. And how they could send six specific AI stocks through the roof on their first day. Click here for the full story… AMED Media Mentions By Week AMED Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMED News Sentiment▼1.720.49▲Average Medical News Sentiment AMED News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMED Articles This Week▼43▲AMED Articles Average Week Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CHE News Today BTSG News Today ADUS News Today AHCO News Today OPCH News Today IRTC News Today IDYA News Today TXG News Today SWTX News Today XENE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMED) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedisys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
